245 related articles for article (PubMed ID: 1314841)
1. Acute improvement in histological outcome by MK-801 following focal cerebral ischemia and reperfusion in the cat independent of blood flow changes.
Dezsi L; Greenberg JH; Hamar J; Sladky J; Karp A; Reivich M
J Cereb Blood Flow Metab; 1992 May; 12(3):390-9. PubMed ID: 1314841
[TBL] [Abstract][Full Text] [Related]
2. Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK-801: effect on volume of ischemic injury.
Iijima T; Mies G; Hossmann KA
J Cereb Blood Flow Metab; 1992 Sep; 12(5):727-33. PubMed ID: 1506440
[TBL] [Abstract][Full Text] [Related]
3. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
Slivka AP; Murphy EJ
Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
[TBL] [Abstract][Full Text] [Related]
4. Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischaemia in the rat.
Park CK; Nehls DG; Teasdale GM; McCulloch J
J Cereb Blood Flow Metab; 1989 Oct; 9(5):617-22. PubMed ID: 2674169
[TBL] [Abstract][Full Text] [Related]
5. The effect of MK-801 on cortical spreading depression in the penumbral zone following focal ischaemia in the rat.
Gill R; Andiné P; Hillered L; Persson L; Hagberg H
J Cereb Blood Flow Metab; 1992 May; 12(3):371-9. PubMed ID: 1314840
[TBL] [Abstract][Full Text] [Related]
6. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.
Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
Ann Neurol; 1988 Oct; 24(4):543-51. PubMed ID: 2853604
[TBL] [Abstract][Full Text] [Related]
7. Prolonged effects of MK-801 in the cat during focal cerebral ischemia and recovery: survival, EEG activity and histopathology.
Dezsi L; Greenberg JH; Sladky J; Araki N; Hamar J; Reivich M
J Neurol Sci; 1994 Jan; 121(1):110-20. PubMed ID: 8133305
[TBL] [Abstract][Full Text] [Related]
8. Effects of hyperglycemia on ischemic brain damage, local cerebral blood flow and ischemic cerebral edema.
Yura S
Hokkaido Igaku Zasshi; 1991 Jan; 66(1):1-15. PubMed ID: 2004735
[TBL] [Abstract][Full Text] [Related]
9. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
Dawson DA; Graham DI; McCulloch J; Macrae IM
Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
[TBL] [Abstract][Full Text] [Related]
10. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia.
Stevens MK; Yaksh TL
J Cereb Blood Flow Metab; 1990 Jan; 10(1):77-88. PubMed ID: 2153692
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.
Ozyurt E; Graham DI; Woodruff GN; McCulloch J
J Cereb Blood Flow Metab; 1988 Feb; 8(1):138-43. PubMed ID: 2892846
[TBL] [Abstract][Full Text] [Related]
12. [Effect of naloxone on focal cerebral ischemia in cats].
Kobayashi H; Hayashi M; Yamamoto S; Farrar JK; Peerless SJ
No Shinkei Geka; 1985 Jan; 13(1):45-50. PubMed ID: 3982594
[TBL] [Abstract][Full Text] [Related]
13. Local cerebral glucose utilization in chronic middle cerebral artery occlusion in the cat.
Komatsumoto S; Greenberg JH; Hickey WF; Reivich M
J Cereb Blood Flow Metab; 1989 Aug; 9(4):535-47. PubMed ID: 2738118
[TBL] [Abstract][Full Text] [Related]
14. [The influence of pentobarbital and Y-9179 on regional cerebral blood flow and infarction size in the middle cerebral artery occlusion model in cats (author's transl)].
Ochiai C; Asano T; Takakura K; Fukuda T; Horizoe H; Morimoto Y
No To Shinkei; 1982 Apr; 34(4):355-64. PubMed ID: 7093072
[TBL] [Abstract][Full Text] [Related]
15. Pre- and postischemic effects of the NMDA receptor antagonist dizocilpine maleate (MK-801) on collateral cerebral blood flow.
Robertson SC; Wetjen NM; Beer BJ; Loftus CM
J Neurosurg; 1997 Dec; 87(6):927-33. PubMed ID: 9384406
[TBL] [Abstract][Full Text] [Related]
16. Temporary and permanent focal cerebral ischemia in the mouse: assessment of cerebral blood flow, brain damage and blood-brain barrier permeability.
Mao Y; Yang G; Zhou L
Chin Med J (Engl); 2000 Apr; 113(4):361-6. PubMed ID: 11775237
[TBL] [Abstract][Full Text] [Related]
17. Effects of fentanyl pretreatment on regional cerebral blood flow in focal cerebral ischemia in rats.
Chi OZ; Hunter C; Liu X; Chokshi SK; Weiss HR
Pharmacology; 2010; 85(3):153-7. PubMed ID: 20150753
[TBL] [Abstract][Full Text] [Related]
18. The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat.
Morikawa E; Ginsberg MD; Dietrich WD; Duncan RC; Kraydieh S; Globus MY; Busto R
J Cereb Blood Flow Metab; 1992 May; 12(3):380-9. PubMed ID: 1569134
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
Yang Y; Li Q; Shuaib A
Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia and focal brain ischemia.
Gisselsson L; Smith ML; Siesjö BK
J Cereb Blood Flow Metab; 1999 Mar; 19(3):288-97. PubMed ID: 10078881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
